OBJECTIVE: Keratin (K)19, a biliary/hepatic progenitor cell (HPC) marker, is expressed in a subset of hepatocellular carcinomas (HCC) with poor prognosis. The underlying mechanisms driving this phenotype of K19-positive HCC remain elusive. DESIGN: Clinicopathological value of K19 was compared with EpCAM, and α-fetoprotein, in a Caucasian cohort of 242 consecutive patients (167 surgical specimens, 75 needle biopsies) with different underlying aetiologies. Using microarrays and microRNA profiling the molecular phenotype of K19-positive HCCs was identified. Clinical primary HCC samples were submitted to in vitro invasion assays and to side population analysis. HCC cell lines were transfected with synthetic siRNAs against KRT19 and submitted to...
Keratin 19 (K19) belongs to the keratin family of proteins, which maintains structural integrity of ...
Purpose: Keratin19 (KRT19) is the smallest known type I intermediate filament and is used as a marke...
BackgroundHepatocellular carcinoma (HCC) is one of the most common malignancies, and the therapeutic...
OBJECTIVE: Keratin (K)19, a biliary/hepatic progenitor cell (HPC) marker, is expressed in a subset o...
Objective: Keratin 19 (K19) expression is a potential predictor of poor prognosis in patients with h...
Keratin (KRT) 19 is a poor prognostic marker for hepatocellular carcinoma (HCC); however, regulatory...
Background: Human hepatocellular carcinoma (HCC) is a heterogeneous disease of distinct clinical sub...
Aims: Cytokeratin (CK) 7 and CK19 expression, present in hepatic progenitor cells (HPCs) and in chol...
The expression of the hepatic progenitor cell marker keratin 19 (K19) in canine hepatocellular carci...
Human hepatocellular carcinomas (HCCs) expressing the biliary/hepatic progenitor cell marker keratin...
<div><p>This retrospective study was designed to investigate the correlation between a novel immunos...
The only present curative option for end-stage liver disease is orthotopic liver transplantation, al...
This retrospective study was designed to investigate the correlation between a novel immunosubtyping...
Cytokeratin 19 (CK-19) is a prognostic indicator of recurrence and metastasis of hepatocellular carc...
Keratins (K) are cytoprotective proteins and keratin mutations predispose to development of multiple...
Keratin 19 (K19) belongs to the keratin family of proteins, which maintains structural integrity of ...
Purpose: Keratin19 (KRT19) is the smallest known type I intermediate filament and is used as a marke...
BackgroundHepatocellular carcinoma (HCC) is one of the most common malignancies, and the therapeutic...
OBJECTIVE: Keratin (K)19, a biliary/hepatic progenitor cell (HPC) marker, is expressed in a subset o...
Objective: Keratin 19 (K19) expression is a potential predictor of poor prognosis in patients with h...
Keratin (KRT) 19 is a poor prognostic marker for hepatocellular carcinoma (HCC); however, regulatory...
Background: Human hepatocellular carcinoma (HCC) is a heterogeneous disease of distinct clinical sub...
Aims: Cytokeratin (CK) 7 and CK19 expression, present in hepatic progenitor cells (HPCs) and in chol...
The expression of the hepatic progenitor cell marker keratin 19 (K19) in canine hepatocellular carci...
Human hepatocellular carcinomas (HCCs) expressing the biliary/hepatic progenitor cell marker keratin...
<div><p>This retrospective study was designed to investigate the correlation between a novel immunos...
The only present curative option for end-stage liver disease is orthotopic liver transplantation, al...
This retrospective study was designed to investigate the correlation between a novel immunosubtyping...
Cytokeratin 19 (CK-19) is a prognostic indicator of recurrence and metastasis of hepatocellular carc...
Keratins (K) are cytoprotective proteins and keratin mutations predispose to development of multiple...
Keratin 19 (K19) belongs to the keratin family of proteins, which maintains structural integrity of ...
Purpose: Keratin19 (KRT19) is the smallest known type I intermediate filament and is used as a marke...
BackgroundHepatocellular carcinoma (HCC) is one of the most common malignancies, and the therapeutic...